Artemis Investment Management LLP raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 8.3% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 121,313 shares of the company’s stock after purchasing an additional 9,309 shares during the quarter. Artemis Investment Management LLP’s holdings in GE HealthCare Technologies were worth $9,453,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of GE HealthCare Technologies by 9.2% in the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock worth $4,410,893,000 after acquiring an additional 4,107,746 shares during the period. Norges Bank bought a new stake in shares of GE HealthCare Technologies in the fourth quarter worth approximately $229,052,000. Capital Research Global Investors boosted its holdings in shares of GE HealthCare Technologies by 5.2% in the first quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock worth $4,908,406,000 after buying an additional 2,647,204 shares during the last quarter. Perpetual Ltd purchased a new position in shares of GE HealthCare Technologies in the first quarter worth approximately $96,135,000. Finally, Jacobs Levy Equity Management Inc. boosted its holdings in shares of GE HealthCare Technologies by 4,959.8% in the first quarter. Jacobs Levy Equity Management Inc. now owns 758,514 shares of the company’s stock worth $68,957,000 after buying an additional 743,523 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.
GE HealthCare Technologies Trading Down 1.1 %
NASDAQ GEHC traded down $0.93 during trading hours on Monday, hitting $82.47. 336,417 shares of the company were exchanged, compared to its average volume of 3,095,320. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The stock has a 50-day moving average price of $79.20 and a 200 day moving average price of $82.79. The stock has a market cap of $37.64 billion, a PE ratio of 24.39, a price-to-earnings-growth ratio of 3.00 and a beta of 1.17. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.05.
GE HealthCare Technologies Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. GE HealthCare Technologies’s payout ratio is 3.51%.
Analyst Ratings Changes
GEHC has been the topic of a number of research reports. Mizuho dropped their price objective on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a report on Wednesday, May 1st. The Goldman Sachs Group initiated coverage on shares of GE HealthCare Technologies in a report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target on the stock. Stifel Nicolaus initiated coverage on shares of GE HealthCare Technologies in a report on Tuesday, August 6th. They set a “buy” rating and a $100.00 price target on the stock. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Finally, Bank of America lowered their price target on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Five analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $94.58.
View Our Latest Analysis on GE HealthCare Technologies
Insider Activity at GE HealthCare Technologies
In related news, CEO Jan Makela sold 66,955 shares of the business’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $81.54, for a total value of $5,459,510.70. Following the completion of the sale, the chief executive officer now owns 63,348 shares in the company, valued at $5,165,395.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Jan Makela sold 66,955 shares of the company’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $81.54, for a total value of $5,459,510.70. Following the sale, the chief executive officer now owns 63,348 shares of the company’s stock, valued at approximately $5,165,395.92. The disclosure for this sale can be found here. Over the last quarter, insiders sold 73,005 shares of company stock worth $5,941,366. Company insiders own 0.27% of the company’s stock.
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- The How And Why of Investing in Oil Stocks
- How to Invest in Silver: A Beginner’s Guide
- What is a Bond Market Holiday? How to Invest and Trade
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.